Form 4: Pulse Biosciences CEO Acquires 10,000 Shares of Common Stock
SEC Form 4
Pulse Biosciences CEO, Burke Thomas Barrett, purchased 10,000 shares of the company's common stock at a price of $8.56 per share on May 20, 2024.
Summary
- On May 20, 2024, Burke Thomas Barrett, the President and CEO of Pulse Biosciences, Inc., acquired 10,000 shares of common stock.
- The purchase price was $8.56 per share.
- Following the transaction, Barrett directly owns 10,000 shares of Pulse Biosciences.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase of shares is generally a good sign, but it's a relatively small transaction and doesn't provide a definitive signal.
Positives
- The CEO's purchase of company stock may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of the stock purchase transaction. |
| 05/22/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.